By: dfitzgerald
For full publication text, download document.
Testimony before the committee on energy and commerce subcommittee on health for the hearing entitled “Examining Options To Combat…
PUBLIC HEARING COMMENTS BEFORE THE FDA ADVISORY COMMITTEE FOR REPRODUCTIVE HEALTH DRUGS: New Drug Application (NDA) 22-474,…
TESTIMONY BEFORE THE COMMITTEE ON ENERGY AND COMMERCE SUBCOMMITTEE ON HEALTH FOR THE HEARING ENTITLED ?DO NEW…